Status:

COMPLETED

ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Ovarian Cancer

Adnexal Mass

Eligibility:

FEMALE

18+ years

Phase:

EARLY_PHASE1

Brief Summary

The purpose of this study is to find out how well ovarian sentinel lymph nodes (SLNs) can be identified with indocyanine green (ICG) dye during risk-reducing ovarian surgery.

Eligibility Criteria

Inclusion

  • Women undergoing surgery with the Gynecology Service at MSK.
  • Women undergoing surgery for an adnexal mass without pre-operative suspicion of high stage disease, with or without a hysterectomy
  • °For this protocol, "suspected high stage disease" will be defined as any patient with radiologic or clinical evidence of ovarian cancer which has spread outside of the ovary. Thus, only patients with an adnexal mass, or bilateral adnexal masses, are eligible.
  • Women in whom MIS surgery is converted to a laparotomy will not be excluded as both surgical approaches, MIS and open, will be utilized.
  • Women \>/= 18 years of age
  • Able to provide informed consent
  • Albumin levels within normal range

Exclusion

  • Current non-GYN primary malignancy
  • Prior or current history of uterine, cervical, peritoneal, or vulvovaginal malignancy
  • Ongoing anticancer therapy
  • Prior bilateral oophorectomy
  • Known severe anaphylactic iodide allergy
  • Known history of cirrhosis or other chronic liver disease, or women with hepatic dysfunction.
  • Elevated transaminases (ALT, AST) and/or Alk Phos will be evaluated by the treating physician on a case by case basis.

Key Trial Info

Start Date :

August 5 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 8 2025

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT04051502

Start Date

August 5 2019

End Date

December 8 2025

Last Update

December 17 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Memorial Sloan Kettering Basking Ridge (Consent only)

Basking Ridge, New Jersey, United States, 07920

2

Memorial Sloan Kettering Monmouth (Consent only)

Middletown, New Jersey, United States, 07748

3

Memorial Sloan Kettering Bergen (Consent only )

Montvale, New Jersey, United States, 07645

4

Memorial Sloan Kettering Commack (Consent only)

Commack, New York, United States, 11725

ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study | DecenTrialz